Active and Passive Immunotherapy for Neurodegenerative Disorders
- 1 July 2008
- journal article
- review article
- Published by Annual Reviews in Annual Review of Neuroscience
- Vol. 31 (1) , 175-193
- https://doi.org/10.1146/annurev.neuro.31.060407.125529
Abstract
Immunotherapeutic strategies to combat neurodegenerative disorders have galvanized the scientific community since the first dramatic successes in mouse models recreating aspects of Alzheimer diseas...Keywords
This publication has 87 references indexed in Scilit:
- Amyloid Deposition Begins in the Striatum of Presenilin-1 Mutation Carriers from Two Unrelated PedigreesJournal of Neuroscience, 2007
- Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosisProceedings of the National Academy of Sciences, 2007
- β-Amyloid Immunotherapy Prevents Synaptic Degeneration in a Mouse Model of Alzheimer's DiseaseJournal of Neuroscience, 2005
- Natural oligomers of the amyloid-β protein specifically disrupt cognitive functionNature Neuroscience, 2004
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004
- Effect of Different Anti-Aβ Antibodies on Aβ Fibrillogenesis as Assessed by Atomic Force MicroscopyJournal of Molecular Biology, 2003
- Microglial activation facilitates Aβ plaque removal following intracranial anti-Aβ antibody administrationNeurobiology of Disease, 2003
- RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brainNature Medicine, 2003
- Short-term β-amyloid vaccinations do not improve cognitive performance in cognitively impaired APP+PS1 mice.Behavioral Neuroscience, 2003
- Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides 1 1Edited by I. A. WilsonJournal of Molecular Biology, 2000